Trasis
Fabrice Morelle currently serves as Directeur général at ERAS LABO since October 2022 and has been a scientist in radiochemistry at Trasis since August 2019. Prior experience includes a role as Research Engineer in Electrochemistry at Plastic Omnium, focusing on R&D for fuel cell systems in the automotive sector, from January 2018 to July 2019. Fabrice completed a PhD at Université catholique de Louvain from September 2013 to October 2017, where the thesis was conducted under Professor Yaroslav Filinchuk on hybrid hydridic Metal-Organic-Frameworks. Additionally, Fabrice was the Président of ACIM (Association des Chercheurs de l'IMCN) from September 2015 to June 2017, representing researchers at the institute. Educational qualifications include a Doctorate in Materials Science and a Master’s degree in Chemical Sciences, both obtained from Université catholique de Louvain.
Trasis
At Trasis our primary focus is allowing the medical community to access new radiolabelled therapeutic and diagnostic substances easier and faster. To this end, we design, manufacture, sell and support high performance synthesizers, dose preparation equipment, their shielding and accessories. We also develop customized synthetic methods and instruments. We can provide GMP Active Pharmaceutical Ingredients (API) and assist our customers with their regulatory affairs. Our proven radiopharmaceutical expertise, coupled with our high end instruments allow us to provide fully integrated solutions for an effective tracer production and faster transition from drug development to marketing authorization. Our equipment is used worldwide in nuclear medicine departments, research centers, radiopharmaceutical production facilities and pharmaceutical companies.